KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Inventory (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Inventory for 17 consecutive years, with $189.0 million as the latest value for Q4 2025.

  • Quarterly Inventory rose 0.53% to $189.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $189.0 million through Dec 2025, up 0.53% year-over-year, with the annual reading at $189.0 million for FY2025, 0.53% up from the prior year.
  • Inventory hit $189.0 million in Q4 2025 for Quest Diagnostics, up from $186.0 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $223.0 million in Q1 2021 to a low of $181.0 million in Q1 2024.
  • Historically, Inventory has averaged $191.4 million across 5 years, with a median of $188.5 million in 2024.
  • Biggest five-year swings in Inventory: soared 76.98% in 2021 and later fell 11.66% in 2022.
  • Year by year, Inventory stood at $208.0 million in 2021, then fell by 7.69% to $192.0 million in 2022, then fell by 1.04% to $190.0 million in 2023, then decreased by 1.05% to $188.0 million in 2024, then rose by 0.53% to $189.0 million in 2025.
  • Business Quant data shows Inventory for DGX at $189.0 million in Q4 2025, $186.0 million in Q3 2025, and $187.0 million in Q2 2025.